Loading…
Vivos Therapeutics expects a 75% interest in AIM Florida.
Vivos Therapeutics, Inc. and South Palm Cardiovascular Associates announced definitive collaboration and operating agreements to form AIM Florida. Vivos expects a 75% interest in the venture, with Palm Beach County Sleep Center slated to begin treating patients in Q1 2027.
The collaboration involves a 75% interest for Vivos Therapeutics in AIM Florida.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.